lung cancer
Lung cancer is what happens when cells lining the airways or the deep lung start to grow out of control, ignoring the body's normal stop signals. Imagine a small repair crew that forgets to stop building: instead of patching damaged tissue and quitting, it keeps multiplying, forming a lump that crowds out healthy lung and can break off to seed other organs.
Most lung cancers begin in the cells of the bronchial tubes or the alveoli, often after years of injury from tobacco smoke or other inhaled carcinogens. Doctors divide them into two broad families with very different behavior and treatment: non-small-cell lung cancer (the large majority) and small-cell lung cancer (a fast, aggressive minority). The exact subtype, stage, and molecular features now guide therapy more than ever.
Lung cancer is the leading cause of cancer death worldwide, largely because it often causes no symptoms until it is advanced. Early disease may be silent or show only a persistent cough or a nodule found by chance on imaging; later signs include coughing blood, weight loss, chest pain, or breathlessness. The good news is that screening of high-risk people and modern targeted and immune treatments have meaningfully improved outcomes for many patients.
It is worth stating plainly: smoking is by far the biggest risk factor, but lung cancer also occurs in people who never smoked, especially certain adenocarcinomas. A diagnosis is never a moral verdict, and the path forward depends on careful staging and tissue testing rather than guesswork.
A 64-year-old long-term smoker has a routine chest X-ray showing a 2 cm mass; a biopsy confirms lung adenocarcinoma, and the team proceeds to stage the disease and test for treatable mutations.
Many lung cancers are first found incidentally on imaging before symptoms develop.
Lung cancer is not one disease. Treatment hinges on distinguishing non-small-cell from small-cell type, accurate staging, and molecular profiling of the tumor tissue.